SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3451Looks like Eli Lily is the key to funding for research just now. mjMJ-8/5/2003
3450Isis Pharmaceuticals Reports Second Quarter 2003 Highlights and Financial Resultbob zagorin-8/5/2003
3449Webcast Alert: Isis Pharmaceuticals Announces Second Quarter Financial Results Wbob zagorin-7/29/2003
3448Skipping improves muscles Small antisense molecules offer hope for Duchenne musSemiBull-7/7/2003
3447Isis Pharmaceutcials and ITRI of Taiwan Initiate SARS Antisense Drug Discovery Ebob zagorin-6/24/2003
3446<<one question, was there any discussion of reformulted affinitac test proMr. Sunshine-6/12/2003
3445thanks much steve. one question, was there any discussion of reformulted affinitbob zagorin-6/11/2003
3444I went to the annual meeting yesterday. I believe most of the presentation isMr. Sunshine-6/11/2003
3443Webcast Alert: Isis Pharmaceuticals to Provide General Corporate Update In Conjubob zagorin-6/9/2003
3442would you be kind enough to post some comments.... tia...bob zagorin-6/9/2003
3441Is anyone going to the Annual Meeting tomorrow? I will try to make it, and woulMr. Sunshine-6/9/2003
3440Isis Pharmaceuticals and Eli Lilly and Company Renegotiate Affinitak(TM) Manufacnigel bates-6/5/2003
3439Isis Pharmaceuticals Provides Summary of American Society of Clinical Oncology Dbob zagorin-6/3/2003
3438Isis Pharmaceuticals Initiates Phase II Clinical Trial of ISIS 14803 in Patientsbob zagorin-5/29/2003
3437Isis Pharmaceuticals Initiates Phase II Clinical Trial of ISIS 14803 in Patientsbob zagorin-5/29/2003
3436They are in tremendous need of product validation IMHO.Keith Fauci-5/24/2003
3435Rating reiterations for May 22 from Briefing.com: Isis Pharm ISIS bob zagorin-5/22/2003
3434Alicaforsen (ISIS 2302) Improves Clinical Symptoms of Pouchitis Patients Resultsbob zagorin-5/21/2003
3433very interesting. anyone familiar with the old RZYM (now RNAI) and care to commebob zagorin-5/19/2003
3432Isis Pharmaceuticals and Ercole Biotech Initiate Collaboration to Create Antisennigel bates-5/19/2003
3431Isis Pharmaceuticals Initiates Phase I Clinical Trial of Second-Generation Antisbob zagorin-5/14/2003
3430Actually, I think it was more of a foul tip into the catcher's mitt, resultituck-5/8/2003
3429Isis Pharmaceuticals Reports Financial Results And Highlights for the First Quarbob zagorin-5/8/2003
3428<i>>>I'll take a swing at this<< And miss big time;</i&Doc Bones-5/7/2003
3427>>I'll take a swing at this<< And miss big time; thanks for thetuck-5/7/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News